ICL Group (ICL) Q2 2026 earnings review

Best Operating Profit in 3 Years, Masking Margin Squeeze in Downstream Segments

ICL delivered a robust Q2 2026, achieving its highest operating income in three years. Consolidated sales accelerated, growing 17% YoY to $2.14B, while Adjusted EBITDA jumped 28% to $448M. However, the quality of this growth is sharply divided. The upstream segments (Potash and Industrial Products) were powerful drivers, fueled by volume recovery and higher prices. Conversely, the downstream segments (Phosphate and Growing Solutions) experienced negative operating leverage, where strong double-digit sales growth was entirely offset by a $100M spike in raw material costs (primarily sulphur). Looking ahead, management reaffirmed FY26 guidance and announced a major strategic pivot for 2027: a restructuring into end-market divisions and a $350M 'Elevate' cost-savings program.

🐂 Bull Case

Potash and Bromine Flex Pricing Power

Industrial Products and Potash delivered exceptional profit growth (+113% and +63% YoY respectively). Potash average realized price (CIF) climbed 13% YoY to $376/tonne, combined with strong production improvements at the Dead Sea.

Cost Efficiency Roadmap Initiated

The newly formalized 'Elevate' program targets $350M in annualized cost savings by the end of 2028. This provides a clear, controllable margin lever regardless of commodity price volatility.

🐻 Bear Case

Sulphur Costs Crushing Downstream Margins

Despite a 13% increase in Phosphate Solutions sales, segment operating income actually declined 11%. Skyrocketing sulphur costs proved impossible to fully pass through to customers, indicating constrained pricing power.

Mounting Geopolitical and FX Headwinds

The continued appreciation of the Israeli shekel cost the company $42M in top-level operating income, while Red Sea shipping disruptions (Houthi attacks) drove up marine transportation costs by $8M for the quarter.

⚖️ Verdict: 🟢

Bullish. The core upstream assets are printing cash and more than compensating for the margin compression in downstream specialties. The proactive restructuring and $350M efficiency program show management is focused on long-term structural profitability rather than just riding the commodity cycle.

Key Themes

CONCERN 🔴

Margin Divergence: Downstream Segments Lagging

A concerning break in trend occurred in the downstream operations. Phosphate Solutions revenue grew 13% YoY, but operating income dropped 11%. Similarly, Growing Solutions revenue grew 12%, but operating income dropped 9%. This directly contradicts the narrative that specialty products provide margin stability. The culprit was a $100M negative operating income impact from raw materials—specifically surging sulphur and commodity fertilizer prices—that pricing adjustments ($111M positive impact across both segments) failed to fully cover.

DRIVER NEW 🟢

Industrial Products and Potash Rebound

The upstream commodity businesses were the unambiguous growth drivers, accelerating dramatically. Industrial Products operating income skyrocketed 113% YoY to $115M, driven by higher prices for elemental bromine and flame retardants. Potash operating income surged 63% to $85M as production volumes rose 11% (1,058k tonnes) due to Dead Sea operational improvements, and realized CIF prices increased $43/tonne YoY to $376.

THEME NEW 🟢

Major Organizational Restructuring and 'Elevate' Program

ICL is fundamentally changing its reporting and operational structure beginning January 2027. The company will transition to three end-market divisions (Nutrition Solutions, Industrial Products, Growing Solutions) and one upstream division (Essential Minerals). Concurrently, ICL formalized the 'Elevate' cost-savings initiative, which aims to deliver $350M in annualized savings by the end of 2028, with significant realization starting in early 2027. This indicates management's push to aggressively align costs with a focus on higher-margin specialty growth.

CONCERN 🔴

Macro Headwinds: FX and Marine Transport Costs

External forces outside of management's control continue to act as a significant drag. The appreciation of the Israeli shekel against the USD created a $42M negative impact on consolidated operating income by inflating local production costs. Additionally, ongoing regional tensions and Houthi attacks in the Red Sea disrupted shipping routes, adding $8M in marine transportation costs during the quarter.

Other KPIs

Operating Cash Flow $290 million

Operating cash flow increased 8% YoY from $269M. The improvement was driven primarily by higher net income, demonstrating that the strong top-line growth and elevated commodity pricing are translating directly into cash generation, despite a $122M outflow for net changes in operating assets and liabilities (working capital build).

Series H Debentures $800 million

In June 2026, ICL fortified its balance sheet by issuing $800 million in senior unsecured notes (Series H) maturing in 2036. The notes carry a 6.036% annual coupon and are rated BBB- by S&P and Fitch. This long-term debt issuance provides ample liquidity to fund capital expenditures and potential future M&A without stressing short-term cash reserves.

Guidance

FY26 Consolidated Adjusted EBITDA $1.5 - $1.7 billion

Stable. The company reiterated its full-year guidance range, which it had previously raised in Q1. The midpoint of $1.6B implies an ~8% acceleration in YoY growth compared to the $1.488B delivered in FY25, heavily reliant on sustained bromine and potash pricing.

FY26 Potash Sales Volumes 4.5 - 4.7 million metric tons

Accelerating. The midpoint (4.6M tons) implies a healthy 6.5% YoY volume growth compared to the 4.32M tons sold in FY25. Q2's 11% production jump validates that ICL's operational improvements at the Dead Sea and in Spain are structurally capable of hitting these elevated targets.

Key Questions

Sulphur Cost Mitigation

With Phosphate Solutions operating margins compressing due to raw material costs, what specific contractual or supply chain levers is ICL pulling to mitigate sulphur volatility in H2 2026?

Elevate Savings Realization

Regarding the $350 million 'Elevate' cost savings target for 2028, how much of these savings are expected to be realized in 2027, and what percentage represents headcount reductions versus raw material/procurement efficiencies?

Nutrition Solutions Synergies

As ICL transitions to the new 'Nutrition Solutions' division in 2027, what immediate revenue synergies or cross-selling opportunities does management expect to unlock by combining food, beverage, health, and wellness into a single unit?

Hedging the Red Sea Disruption

Marine transportation costs continue to drag on profitability due to geopolitical tensions. Is the company altering its geographic sales mix or entering into longer-term freight forward agreements to protect margins heading into Q3?